Allen Institute for Immunology
Biotechnology ResearchWashington, United States51-200 Employees
The Allen Institute for Immunology is a biotechnology research organization focused on understanding the dynamics of the human immune system, including how it distinguishes between threats and the body's own cells and what goes wrong during illness. Headquartered in Seattle, Washington, it lists a workforce of 51 to 200 employees. The institute seeks to advance immune health and improve the diagnosis, treatment, and prevention of immune-related diseases, with research that centers on patients living with these conditions. Recent activity includes partnerships and collaborations with the Paul G. Allen Frontiers Group and related initiatives, such as EverythingALS and Vision 2030, to accelerate research into ALS and identify potential therapeutic targets. The organization reports annual revenue in the range of $10 million to $25 million.